Literature DB >> 9406961

Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens.

G Zhang1, T F Murray, D K Grandy.   

Abstract

The activity of the recently isolated endogenous opioid-like peptide orphanin FQ (OFQ) was measured in two classical bioassays of opioid action. OFQ potently and concentration-dependently suppressed the electrically stimulated contractions of the guinea pig ileum (GPI) and the mouse vas deferens (MVD) with EC50 values of 1.82 +/- 0.16 and 2.97 +/- 0.01 nM, and Emax values of 56 +/- 3% and 96 +/- 4%, respectively. This effect of OFQ, in both the GPI and MVD, was insensitive to the opioid receptor antagonist naloxone. OFQ competed with [3H]diprenorphine binding to mu-, delta- or kappa-opioid receptors stably expressed in Chinese hamster ovary cell lines with IC50 values of 2.1 +/- 0.4, 2.2 +/- 0.3, 0.75 +/- 0.3 microM, respectively. Low affinity for the classical opioid receptors together with the inability of naloxone to antagonize its effect suggest that the inhibitory action of OFQ is mediated via a distinct OFQ receptor in the GPI and MVD. Consequently, the MVD could serve as a valuable bioassay of potential OFQ receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406961     DOI: 10.1016/s0006-8993(97)00858-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.

Authors:  R Bigoni; G Calo; R Guerrini; J W Strupish; D J Rowbotham; D G Lambert
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

2.  Effects of nociceptin/orphanin FQ on rats with cathartic colon.

Authors:  Hai-Yan Li; Xiang Yan; Quan-Lai Xue; Yong-Ning Zhou; Yan Gao; Rui Wang; Yong-Ming Liu; Jun-Tao Ran
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.

Authors:  M Ho; A D Corbett; A T McKnight
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 4.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Nociceptin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localization.

Authors:  Andrei Sibaev; Jakub Fichna; Dieter Saur; Birol Yuece; Jean-Pierre Timmermans; Martin Storr
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

6.  Diabetes-induced changes in the morphology and nociceptinergic innervation of the rat uterus.

Authors:  Saeed Tariq; Syed M Nurulain; Hameed Rashed; Mohamed Lotfy; Starling Bright Emerald; Surya Koturan; Kornélia Tekes; Ernest Adeghate
Journal:  J Mol Histol       Date:  2015-11-20       Impact factor: 2.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.